Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.31 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | HTT | P42858 | 3/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 3/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10331568 | 0.97 | PGR (0.34) | PGRMAPTSMN1; SMN2NPSR1P2RX4 | |
| SCHEMBL10331567 | 0.97 | PGR (0.35) | PGRMAPTSMN1; SMN2NPSR1KMT2A | |
| SCHEMBL21578630 | 0.93 | FAAH (0.35) | PGRHTTADAMTS5ALDH1A1 | |
| SCHEMBL13557553 | 0.91 | PGR (0.33) | PGRMAPTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL17278584 | 0.91 | ADORA2A (0.33) | MAPTSMN1; SMN2NPSR1KMT2AMEN1 | |
| SCHEMBL17278509 | 0.91 | ADORA2A (0.33) | MAPTSMN1; SMN2NPSR1KMT2AMEN1 | |
| SCHEMBL15084758 | 0.89 | ADORA1 (0.33) | MAPTSMN1; SMN2NPSR1HTTALDH1A1 | |
| SCHEMBL10331566 | 0.89 | PGR (0.41) | PGRMAPTSMN1; SMN2NPSR1KMT2A | |
| SCHEMBL13557712 | 0.89 | PGR (0.41) | PGRMAPTSMN1; SMN2NPSR1KMT2A | |
| SCHEMBL10820306 | 0.89 | PGR (0.41) | PGRMAPTSMN1; SMN2NPSR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200251659-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | DOOSAN CORPORATION (KR) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200251659-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | VDAC1, OR10J3, PIEZO1 | PGR 3783/4885MAPT 660/4885SMN1; SMN2 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.